Experienced in Relapsing Polychondritis

Frederic A. Houssiau

Cliniques Universitaires Saint Luc, Pôle De Pathologies Rhumatismales Inflammatoires Et Systémiques, UCLouvain
Brussels, BRU, BE 
Experienced in Relapsing Polychondritis
Cliniques Universitaires Saint Luc, Pôle De Pathologies Rhumatismales Inflammatoires Et Systémiques, UCLouvain
Brussels, BRU, BE 
OverviewLocationsClinical Research

Overview

Frederic Houssiau practices in Brussels, Belgium. Mr. Houssiau is rated as an Experienced expert by MediFind in the treatment of Relapsing Polychondritis. His top areas of expertise are Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Glomerulonephritis, Scleroderma, and Kidney Transplant.

His clinical research consists of co-authoring 133 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Relapsing Polychondritis.

Gender
Male

Locations

Cliniques Universitaires Saint Luc, Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, UCLouvain
Brussels, BRU, Belgium
Other Locations
Leuven, VLG, Belgium
Cliniques Universitaires Saint Luc, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNα-Kinoid in Adult Subjects With Systemic Lupus Erythematosus
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNα-Kinoid in Adult Subjects With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: April 09, 2020
Intervention Type: Biological, Other
Study Phase: Phase 2
A Phase I-II, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study of Neovacs' IFNα-Kinoid in Adult Subjects With Systemic Lupus Erythematosus.
A Phase I-II, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study of Neovacs' IFNα-Kinoid in Adult Subjects With Systemic Lupus Erythematosus.
Enrollment Status: Completed
Publish Date: March 21, 2019
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

133 Total Publications

Obesity is an independent poor prognostic factor in lupus nephritis.
Obesity is an independent poor prognostic factor in lupus nephritis.
Journal: Lupus
Published: September 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Houssiau's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile